A novel biotherapeutic treatment for prostate cancer
Ended Block Grant Awarded Last action
- Award ID
- R43CA130228
- Recipient
-
Bexion Pharmaceuticals, Inc. UEI HJPDQTK95NS8
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $145,306
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Place of performance
- Ohio, USA
Award details come from USAspending.gov.
Quick answers
Who received award R43CA130228?
R43CA130228 was awarded to Bexion Pharmaceuticals, Inc. by National Institutes of Health (Department of Health and Human Services) on September 1, 2007.
How much is award R43CA130228 worth?
$145,306 has been obligated on R43CA130228.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award